Diabetic Patients with Gastro-Esophageal Reflux Disease: Comparison Between Two Self-Report Questionnaires.

Document Type : Original Article

Authors

1 Endemic Medicine Department, Faculty of Medicine, Cairo University

2 Tropical medicine department - Faculty of Medicine - Beni-Suef University

3 Internal Medicine department, Faculty of Medicine, Beni-Suef University, Egypt

4 Specialist, endemic heptogastroenterology department, Ahmed Maher Teaching hospital

5 Clinical and Chemical Pathology department - Faculty of Medicine - Cairo University

6 Internal medicine department Faculty of Medicine, Cairo University

Abstract

Background: Patients with diabetes mellitus (DM) are more likely to have gastroesophageal reflux disease (GERD), and there is a significant association between the two conditions.  A variety of tools, including endoscopy, pH monitoring, and proton pump inhibitor (PPI) test, are available for the diagnosis of GERD. GERD is very prevalent among the majority of people; thus it is highly appealing to apply low-cost, simple methods for identifying high-risk people who might be suffering from it.   Aim: To assess the diagnostic usefulness of the Carlsson-Dent (CD) questionnaire and the frequency scale for detecting the symptoms of the gastroesophageal reflux disease (FSSG) questionnaire as a self-assessment diagnostic instrument in diabetic patients and its relationship with diabetes complications. Patients and methods: This cross-sectional study included 217 adult diabetic patients; 153 females, 64 males who were enrolled in two Endocrinology clinics; the Cairo University hospitals and Beni-Sweif University hospitals from June 2023 to December 2023. All patients were subjected to both CD and FSSG questionnaires (CDQ & FSSGQ respectively). Relevant clinical and laboratory data were gathered such as body mass index (BMI), diabetes control, other comorbidities, added to abdominal ultrasonography. Results: Using the CD questionnaire, GERD was reported in 66% of the study population versus a prevalence of 53% with the FSSGQ. There was a significant agreement between the two questionnaires: of 81.6%, p <0.0001. The presence of hypertension and liver steatosis were significantly associated with GERD diagnosis by the CDQ (P-value 0.03 and 0.004 respectively) and FSSGQ (P-value 0.01 for both). Additionally, NSAID intake, as well as peripheral neuropathy, were associated with GERD using the CDQ (P-value 0.03 and 0.004 respectively). Dyslipidemia was associated with GERD using the FSSGQ (P-value 0.008). Conclusion: A relatively high incidence of GERD symptoms in diabetic patients was observed. There was a significant agreement between the CD and FSSG questionnaires. Hypertension, liver steatosis, dyslipidemia, peripheral neuropathy, and NSAID intake were associated with GERD in diabetics.

Keywords

Main Subjects

References

  1. Wiesner, A., Zwolińska-Wcisło, M., &Paśko, P. (2021). Effect of food and dosing regimen on safety and efficacy of proton pump inhibitors therapy—a literature review. International Journal of Environmental Research and Public Health, 18(7), 3527.
  2. Jarosz, M., &Taraszewska, A. (2014). Risk factors for gastroesophageal reflux disease–the role of diet. Gastroenterology Review/PrzeglądGastroenterologiczny, 9(5), 297-301.
  3. Moraes-Filho, J. P. P., Navarro-Rodriguez, T., Eisig, J. N., Barbuti, R. C., Chinzon, D., & Quigley, E. M. (2009). Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics, 64, 785-790.
  4. Lee, S. D., Keum, B., Chun, H. J., & Bak, Y. T. (2011). Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. Journal of neurogastroenterology and motility, 17(3), 274.
  5. El-Serag, H. B., Sweet, S., Winchester, C. C., & Dent, J. (2014). Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut, 63(6), 871-880.
  6. Nonaka, T., Kessoku, T., Ogawa, Y., Yanagisawa, S., Shiba, T., Sakaguchi, T., ... & Inamori, M. (2013). Comparative study of 2 different questionnaires in Japanese patients: the quality of life and utility evaluation survey technology questionnaire (QUEST) versus the frequency scale for the symptoms of gastroesophageal reflux disease questionnaire (FSSG). Journal of neurogastroenterology and motility, 19(1), 54.
  7. Kusano, M., Shimoyama, Y., Sugimoto, S., Kawamura, O., Maeda, M., Minashi, K., ... & Mori, M. (2004). Development and evaluation of FSSG: frequency scale for the symptoms of GERD. Journal of gastroenterology, 39, 888-891.
  8. Carlsson, R., Dent, J., Bolling-Sternevald, E., Johnsson, F., Junghard, O., Lauritsen, K., ... & Lundell, L. (1998). The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scandinavian journal of gastroenterology, 33(10), 1023-1029.
  9. Stanghellini, V., Armstrong, D., Mönnikes, H., & Bardhan, K. D. (2007). Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?. Digestion, 75(Suppl. 1), 3-16.
  10. Fass, R. (2007). Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. Journal of clinical gastroenterology, 41(5), 437-444.
  11. Nonaka, T., Kessoku, T., Ogawa, Y., Yanagisawa, S., Shiba, T., Sakaguchi, T., ... & Inamori, M. (2013). Comparative study of 2 different questionnaires in Japanese patients: the quality of life and utility evaluation survey technology questionnaire (QUEST) versus the frequency scale for the symptoms of gastroesophageal reflux disease questionnaire (FSSG). Journal of neurogastroenterology and motility, 19(1), 54.
  12. World Health Organization. (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation.
  13. American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl. 1): S62-S69. Erratum in: Diabetes Care, 33, e57.
  14. World Health Organization, & International Society of Hypertension Writing Group. (2003). 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of hypertension, 21(11), 1983-1992.
  15. Boulton, K.H. & Dettmar, P.W. (2022). A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Annals of Esophagus, 5, 7.‏
  16. Mare, R., & Sporea, I. (2022). Gastrointestinal and liver complications in patients with diabetes mellitus—A review of the literature. Journal of Clinical Medicine, 11(17), 5223.
  17. Kaplan, M., Tanoglu, A., Sakin, Y. S., Akyol, T., Oncu, K., Kara, M., & Yazgan, Y. (2016). Landmark reading alterations in patients with gastro-oesophageal reflux symptoms undergoing diagnostic gastroscopy. Arab journal of gastroenterology, 17(4), 176-180.
  18. AlTassan, F. M., Al-Khowaiter, S. S., Alsubki, H. E., Alhamoud, W. A., Niazi, A. K., &AlJarallah, B. M. (2020). Prevalence of gastro-esophageal reflux in diabetic patients at a tertiary hospital in Central Saudi Arabia. Saudi medical journal, 41(2), 151.
  19. Quach, D. T., & Phan, B. T. (2022). A Long Duration of Reflux Symptoms is the Predominant Risk Factor for Depression in Vietnamese Patients with Gastroesophageal Reflux Disease. Neuropsychiatric Disease and Treatment, 2141-2150.
  20. Valdez-Solis, E. M., Ramírez-Rentería, C., Ferreira-Hermosillo, A., Molina-Ayala, M., Mendoza-Zubieta, V., & Rodríguez-Pérez, V. (2017). Gastroesophageal reflux disease in patients with long standing type 1 diabetes mellitus: utility of two self-report questionnaires in a multifactorial disease. Colombia Médica, 48(3), 132-137.
  21. Jones, B., & Ravich, W. J. (2012). Establishing a comprehensive center for diagnosis and therapy of swallowing Disorders. In Manual of Diagnostic and Therapeutic Techniques for Disorders of Deglutition(pp. 3-10). New York, NY: Springer New York.
  22. Miyamoto, M., Haruma, K., Takeuchi, K., & Kuwabara, M. (2008). Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy. Journal of gastroenterology and hepatology, 23(5), 746-751.
  23. Contreras-Omana, R., Sanchez-Reyes, O., & Angeles-Granados, E. (2017). Comparison of the Carlsson-Dent and GERD-Q questionnaires for gastroesophageal reflux disease symptom detection in a general population. Revista de Gastroenterología de México (English Edition), 82(1), 19-25.
  24. Kariri, A. M., Darraj, M. A., Wassly, A., Arishi, H. A., Lughbi, M., Kariri, A., ... &Khawaji, B. (2020). Prevalence and risk factors of gastroesophageal reflux disease in Southwestern Saudi Arabia. Cureus, 12(1).
  25. Zein, A. F. M. Z., Sulistiyana, C. S., Permatasari, T. O., Khasanah, U., Pratamawati, T. M., Ismayanti, I., ... &Suhaeni, E. (2022). The prevalence and habit-associated risk factors of gastroesophageal reflux disease among fishermen in Indonesia. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 22(3), 174-179.
  26. Chang, P., & Friedenberg, F. (2014). Obesity and GERD. Gastroenterology Clinics, 43(1), 161-173.
  27. Eusebi, L. H., Ratnakumaran, R., Yuan, Y., Solaymani-Dodaran, M., Bazzoli, F., & Ford, A. C. (2018). Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut, 67(3), 430-440.
  28. Nocon, M., Labenz, J., & Willich, S. N. (2006). Lifestyle factors and symptoms of gastro‐oesophageal reflux–a population‐based study.Alimentary pharmacology & therapeutics, 23(1), 169-174.
  29. Hsu, C. S., Wang, P. C., Chen, J. H., Su, W. C., Tseng, T. C., Chen, H. D., ... & Chao, Y. C. (2011). Increasing insulin resistance is associated with increased severity and prevalence of gastro‐oesophageal reflux disease.Alimentary pharmacology & therapeutics, 34(8), 994-1004.
  30. Gong, Y., Zeng, Q., Yan, Y., Han, C., & Zheng, Y. (2019). Association between lifestyle and gastroesophageal reflux disease questionnaire scores: a cross-sectional study of 37 442 chinese adults. Gastroenterology research and practice, 2019.
  31. Hirata, A., Kishida, K., Nakatsuji, H., Inoue, K., Hiuge-Shimizu, A., Funahashi, T., & Shimomura, I. (2012). High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome. Nutrition & metabolism, 9, 1-6.
  32. He, Y., Duan, Z. J., Wang, C. F., Wei, Y. S., & Cai, M. X. (2022). Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 199-207.
  33. Li, Z. T., Ji, F., Han, X. W., Wang, L., Yue, Y. Q., & Wang, Z. G. (2018). The role of gastroesophageal reflux in provoking high blood pressure episodes in patients with hypertension. Journal of clinical gastroenterology, 52(8), 685.
  34. Nandyal, S., Suria, S., Chogtu, B., & Bhattacharjee, D. (2017). Risk of GERD with diabetes mellitus, hypertension and bronchial asthma–a hospital based retrospective cohort study. Journal of Clinical and Diagnostic Research: JCDR, 11(7), OC25.
  35. Wang, X., Pitchumoni, C. S., Chandrarana, K., & Shah, N. (2008). Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World journal of gastroenterology: WJG, 14(5), 709.
  36. Lee, S. D., Keum, B., Chun, H. J., & Bak, Y. T. (2011). Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. Journal of neurogastroenterology and motility, 17(3), 274.
  37. Rouf, M. A., Khan, M., Sharif, J. U., Karim, M. R., Rahman, M. M., Ahmed, H., ... & Akhter, H. (2017). Prevalence of GERD in Type II Diabetes Mellitus Patients Admitted in A Tertiary Care Hospital of Bangladesh. Mymensingh Medical Journal: MMJ, 26(4), 710-715.
  38. Almadi, M. A., Almousa, M. A., Althwainy, A. F., Altamimi, A. M., Alamoudi, H. O., Alshamrani, H. S., ... &Aljebreen, A. M. (2014). Prevalence of symptoms of gastroesopahgeal reflux in a cohort of Saudi Arabians: a study of 1265 subjects. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association, 20(4), 248.
  39. Alkhathami, A. M., Alzahrani, A. A., Alzhrani, M. A., Alsuwat, O. B., & Mahfouz, M. E. M. (2017). Risk factors for gastroesophageal reflux disease in Saudi Arabia. Gastroenterology Research, 10(5), 294.
  40. Sun, X. M., Tan, J. C., Zhu, Y., & Lin, L. (2015). Association between diabetes mellitus and gastroesophageal reflux disease: a meta-analysis. World Journal of Gastroenterology: WJG, 21(10), 3085.
  41. Boronikolos, G. C., Menge, B. A., Schenker, N., Breuer, T. G., Otte, J. M., Heckermann, S., ... & Meier, J. J. (2015). Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance. Diabetologia, 58, 1175-1182.
  42. Abu-Freha, N., Gat, R., Philip, A., Yousef, B., Ben Shoshan, L., Yardeni, D., ... & Etzion, O. (2021). Indications and findings of upper endoscopies in males and females, are they the same or different?. Journal of Clinical Medicine, 10(8), 1620.

 

Egyptian Journal of Medical Research
Volume 5, Issue 4
October 2024
Pages 193-207

Files

Share

How to cite

Statistics